Robert Andrew Douglas - May 17, 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO ResMed Inc.
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Stock symbol
RMD
Transactions as of
May 17, 2021
Transactions value $
-$1,094,080
Form type
4
Date filed
5/19/2021, 12:49 PM
Next filing
Jun 16, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$1.56M -8K -47.72% $195.00 8.77K May 17, 2021 Direct F1
transaction RMD ResMed Common Stock Options Exercise $466K +8K +91.25% $58.24 16.8K May 17, 2021 Direct F1, F2
holding RMD ResMed Common Stock 210K May 17, 2021 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -8K -5.33% $0.00 142K May 17, 2021 ResMed Common Stock 8K $58.24 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 65.09 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.
F3 Represents date options first became exercisable. Options vest 1/3 per year.